How many clinical trials are studying SHR-1316?

3 recruiting trials in our tracked data involve SHR-1316.

What conditions is SHR-1316 being studied for?

In our tracked recruiting trials, SHR-1316 is being studied in trials for Breast Cancer, Breast Neoplasm, Breast Tumors.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 1 Phase 2 3

Condition	Trials
Breast Cancer	2
Breast Neoplasm	1
Breast Tumors	1
Early-stage Breast Cancer	1
HER2-negative Breast Cancer	1
HER2-positive Breast Cancer	1
Hormone Receptor Negative Tumor	1
Hormone Receptor Positive Tumor	1
Locally Advanced Breast Cancer	1
Lung cancer	1
Non-small Cell Lung Cancer (NSCLC)	1
Triple-Negative Breast Cancer (TNBC)	1
Triple-negative Breast Cancer	1

A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
NCT06754930 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
Reverse Triple Negative Immune Resistant Breast Cancer
NCT05076682 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location